Research menu
Jump to menu

Publications:  Dr Arturas Volianskis

Wang JX, Irvine MW, Burnell ES, Sapkota K, Thatcher RJ, Li M, Simorowski N, Volianskis A et al.(2020). Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors. Nature Communications vol. 11, (1)
Irvine MW, Fang G, Sapkota K, Burnell ES, Volianskis A, Costa BM, Culley G, Collingridge GL et al.(2019). Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid. European Journal of Medicinal Chemistry vol. 164, 471-498.
Ingram R, Kang H, Lightman S, Jane DE, Bortolotto ZA, Collingridge GL, Lodge D, Volianskis A(2018). Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology vol. 142, 30-40.
Lodge D, Watkins JC, Bortolotto ZA, Jane DE, VOLIANSKIS A(2018). The 1980s: D-AP5, LTP and a decade of NMDA receptor discoveries. Neurochemical Research
Sapkota K, Irvine MW, Fang G, Burnell ES, Bannister N, Volianskis A, Culley GR, Dravid SM et al.(2017). Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives. Neuropharmacology vol. 125, 64-79.
Tidball P, Burn HV, Teh KL, Volianskis A, Collingridge GL, Fitzjohn SM(2017). Differential ability of the dorsal and ventral rat hippocampus to exhibit group I metabotropic glutamate receptor-dependent synaptic and intrinsic plasticity. Brain Neurosci Adv vol. 1, (1)
France G, Fernández-Fernández D, Burnell ES, Irvine MW, Monaghan DT, Jane DE, Bortolotto ZA, Collingridge GL et al.(2017). Multiple roles of GluN2B-containing NMDA receptors in synaptic plasticity in juvenile hippocampus. Neuropharmacology vol. 112, 76-83.
Irvine MW, Fang G, Eaves R, Mayo-Martin MB, Burnell ES, Costa BM, Culley GR, Volianskis A et al.(2015). Synthesis of a series of novel 3,9-disubstituted phenanthrenes as analogues of known N-methyl-D-aspartate receptor allosteric modulators. Synthesis (Germany) vol. 47, (11) 1593-1610.
Volianskis A, France G, Jensen MS, Bortolotto ZA, Jane DE, Collingridge GL(2015). Long-term potentiation and the role of N-methyl-D-aspartate receptors. Brain Research vol. 1621, 5-16.
Volianskis A, France G, Jensen MS, Bortolotto ZA, Jane DE, Collingridge GL(2015). Long-term potentiation and the role of N-methyl-d-aspartate receptors. Brain Research
Irvine MW, Fang G, Eaves R, Mayo-martin MB, Burnell ES, Costa BM, Culley GR, Volianskis A et al.(2014). Synthesis of a Series of Novel 3,9-Disubstituted Phenanthrenes as Analogues of Known N-Methyl-d-aspartate Receptor Allosteric Modulators. Synthesis (Germany)
Park P, Volianskis A, Sanderson TM, Bortolotto ZA, Jane DE, Zhuo M, Kaang BK, Collingridge GL(2014). NMDA receptor-dependent long-term potentiation comprises a family of temporally overlapping forms of synaptic plasticity that are induced by different patterns of stimulation. Philosophical Transactions of the Royal Society B: Biological Sciences vol. 369, (1633)
Volianskis A, Collingridge GL, Jensen MS(2013). The roles of STP and LTP in synaptic encoding. PeerJ vol. 2013, (1)
Volianskis A, Bannister N, Collett VJ, Irvine MW, Monaghan DT, Fitzjohn SM, Jensen MS, Jane DE et al.(2013). Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in vitro. Journal of Physiology vol. 591, (4) 955-972.
Lodge D, Tidball P, Mercier MS, Lucas SJ, Hanna L, Ceolin L, Kritikos M, Fitzjohn SM et al.(2013). Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptors. Neuropharmacology vol. 74, 135-146.
Collingridge GL, Volianskis A, Bannister N, France G, Hanna L, Mercier M, Tidball P, Fang G et al.(2013). The NMDA receptor as a target for cognitive enhancement. Neuropharmacology vol. 64, 13-26.
Ceolin L, Bortolotto ZA, Bannister N, Collingridge GL, Lodge D, Volianskis A(2012). A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus. Neurochemistry International vol. 61, (4) 517-522.
Irvine MW, Costa BM, Volianskis A, Fang G, Ceolin L, Collingridge GL, Monaghan DT, Jane DE(2012). Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-d-aspartate receptors. Neurochemistry International vol. 61, (4) 593-600.
Volianskis A, Køstner R, Mølgaard M, Hass S, Jensen MS(2010). Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis. Neurobiology of Aging vol. 31, (7) 1173-1187.
Volianskis A, Jensen MS(2003). Transient and sustained types of long-term potentiation in the CA1 area of the rat hippocampus. Journal of Physiology vol. 550, (2) 459-492.
Volianskis A, Jensen MS (2000). Retained short term potentiation in the CA1 area of rat hippocampus. EUROPEAN JOURNAL OF NEUROSCIENCE. vol. 12, 460-460.
Return to top